Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 32NIH 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Fatigue 2Depression 2Colorectal Neoplasms 2Colonic Neoplasms 2Anxiety Disorders 2Sleep Wake Disorders 1Rectal Neoplasms 1Pain 1Fallopian Tube Neoplasms 1Brenner Tumor 1Breast Neoplasms 1Body Weight Changes 1Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Counseling × Clear all
NCT01453452 2020-01-18

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

SWOG Cancer Research Network

Phase NA Completed
50 enrolled
BreastGastrointestinal

Anxiety Disorders, Body Weight Changes, Breast Neoplasms, Colonic Neoplasms, Depression, Fatigue, Pain, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡